HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glyceollin-containing fermented soybeans improve glucose homeostasis in diabetic mice.

AbstractOBJECTIVE:
Our previous in vitro study demonstrated that glyceollins help normalize glucose homeostasis by potentiating β-cell function and survival in insulinoma cells as well as improving glucose utilization in adipocytes. Here, we investigated whether fermented soybeans containing glyceollins had an antidiabetic action in type 2 diabetic animals.
METHODS:
The diabetic mice, their diabetes induced by intraperitoneal injections of streptozotocin (20 mg/kg bw), were administered a high fat diet with no soybeans (control), 10% unfermented soybeans and 10% fermented soybeans containing glyceollins, respectively, (FSG) for 8 weeks. As positive controls, rosiglitazone (20 mg/kg/bw) was given to diabetic mice fed a no soybean diet and non-diabetic mice were also placed on the same diet.
RESULTS:
Among the diabetic mice, FSG-treated mice exhibited the lowest peak for blood glucose levels with an elevation of serum insulin levels during the first part of oral glucose tolerance testing. FSG also made blood glucose levels drop quickly after the peak and it decreased blood glucose levels more than the control during insulin tolerance testing. This improvement was associated with increased hepatic glycogen accumulation and decreased triglyceride storage. The phosphorylation of Akt, AMP-kinase, and acetyl-CoA carboxylase in the liver was potentiated by FSG, whereas phosphoenolpyruvate carboxykinase expression decreased. The enhancement of glucose homeostasis was comparable to the effect induced by rosiglitazone, a commercial peroxisome proliferator-activated receptor-γ agonist, but it did not match the level of glucose homeostasis in the non-diabetic mice.
CONCLUSION:
Glyceollin-containing FSG improves glucose homeostasis, partly by enhancing hepatic insulin sensitivity in type 2 diabetic mice.
AuthorsSunmin Park, Da Sol Kim, Jeong Hwan Kim, Jong Sang Kim, Hyo Jung Kim
JournalNutrition (Burbank, Los Angeles County, Calif.) (Nutrition) Vol. 28 Issue 2 Pg. 204-11 (Feb 2012) ISSN: 1873-1244 [Electronic] United States
PMID21917419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Peroxisome Proliferator-Activated Receptors
  • Pterocarpans
  • Thiazolidinediones
  • Triglycerides
  • Rosiglitazone
  • glyceollin
  • Glycogen
Topics
  • Animals
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Experimental (diet therapy)
  • Diet, High-Fat
  • Fermentation
  • Glucose Tolerance Test
  • Glycogen (metabolism)
  • Homeostasis
  • Hypoglycemic Agents (pharmacology, therapeutic use)
  • Insulin (blood)
  • Liver (drug effects, enzymology, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Peroxisome Proliferator-Activated Receptors (agonists)
  • Phosphorylation
  • Pterocarpans (pharmacology, therapeutic use)
  • Rosiglitazone
  • Soybeans (chemistry)
  • Thiazolidinediones (pharmacology)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: